Naturally Acquired Antibodies against Four Enterococcus faecalis Capsular Polysaccharides in Healthy Human Sera
- 1 August 2005
- journal article
- Published by American Society for Microbiology in Clinical and Vaccine Immunology
- Vol. 12 (8) , 930-4
- https://doi.org/10.1128/cdli.12.8.930-934.2005
Abstract
Healthy human sera (HHS) contain naturally acquired enterococcal antibodies which promote neutrophil-mediated killing. The target antigens remain unknown. The present study used a capsular polysaccharide (CPS)-enzyme-linked immunosorbent assay (ELISA) to investigate whether the HHS antibodies of 12 healthy donors bound to the CPS of four E. faecalis serotypes (CPS-A to CPS-D) and then employed an opsonic-killing assay to determine if these antibodies mediated phagocyte-dependent killing. All HHS contained immunoglobulin G (IgG) and IgM antibodies directed against capsular polysaccharides of the four serotypes. Absorption of the sera with homologous and heterologous strains showed a majority of antibodies to be cross-reactive among the prototype strains. The susceptibility of the four prototype strains to opsonic killing varied. Opsonic killing of CPS-A and CPS-B strains was significantly higher than killing of CPS-C and CPS-D strains. Absorption studies revealed that the opsonic killing of HHS was only partially type specific, with cross-reactivity between CPS-A and CPS-B strains and between CPS-C and CPS-D strains. These data indicate that healthy individuals possess opsonic antibodies specific for CPS-A and CPS-B but only low titers of opsonic antibodies against CPS-C and CPS-D. Titers of opsonic antibodies did not correlate with antibody titers measured by ELISA. Whether this lack of correlation is due to the low frequency of opsonic antibodies or to increased resistance to the opsonophagocytic killing of some serotypes remains to be determined.Keywords
This publication has 23 references indexed in Scilit:
- Serological and Genetic Diversity of Capsular Polysaccharides in Enterococcus faecalisJournal of Clinical Microbiology, 2004
- Enterococcal infections: host response, therapeutic, and prophylactic possibilitiesVaccine, 2003
- Natural Development of Antibodies to Pneumococcal Capsular Polysaccharides Depends on the Serotype: Association with Pneumococcal Carriage and Acute Otitis Media in Young ChildrenThe Journal of Infectious Diseases, 2001
- Specific antibody promotes opsonization and PMN-mediated killing of phagocytosis-resistantEnterococcus faeciumFEMS Immunology & Medical Microbiology, 2000
- Prophylactic and Therapeutic Efficacy of Antibodies to a Capsular Polysaccharide Shared among Vancomycin-Sensitive and -Resistant EnterococciInfection and Immunity, 2000
- Antibody to Capsular Polysaccharide ofStreptococcus pneumoniaeat the Time of Hospital Admission for Pneumococcal PneumoniaThe Journal of Infectious Diseases, 2000
- Analysis of a Gene Cluster ofEnterococcus faecalisInvolved in Polysaccharide BiosynthesisInfection and Immunity, 2000
- Multiple-Drug Resistant Enterococci: The Nature of the Problem and an Agenda for the FutureEmerging Infectious Diseases, 1998
- Cross-reactions of polysaccharides of staphylococci and streptococci in antipneumococcal and other antiseraMolecular Immunology, 1984
- Carriage of group D streptococci in the human bowel.Journal of Clinical Pathology, 1978